Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The association between Toxoplasma gondii infection and asthma in the United States: A cross-sectional survey analysis

View ORCID ProfileHeather Anholt
doi: https://doi.org/10.1101/2024.05.08.24307043
Heather Anholt
1School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Heather Anholt
  • For correspondence: hezyvet{at}gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The hygiene hypothesis proposes that declining exposure to microbial influences early in life is implicated in the rising trend of allergy and asthma in high-income societies. Approximately 8% of Americans have been diagnosed with asthma, representing 25 million people, and understanding how the human microbiome affects asthma could help guide exposure recommendations or microbe-based therapeutics. Toxoplasma gondii is a common gastro-intestinal microorganism that may modulate immune function. We used a cross-sectional study design to examine a public database of U.S. residents aged 6 to 80 years or older from the 2012-2014 survey cycles of the American National Health and Nutrition Examination Survey (NHANES) to construct an ordinal logistic regression model of the relationship between T. gondii infection and asthma. There was no significant relationship detected between T. gondii infection and asthma when the model was adjusted for key demographic factors.

Asthma is a complex syndrome characterized by increased bronchial reactivity and airway obstruction and can result in death (1). Approximately 8% of Americans have been diagnosed with asthma, representing 25 million people (1–2). Between 1980 and 2011, the prevalence of asthma in the United States (U.S.) more than doubled and similar trends have been observed in other highly industrialized nations (2,4).

The hygiene hypothesis proposes that declining exposure to microbial influences early in life is implicated in the rising trend of allergy and asthma in high-income societies. Children who grow up on a farm are at lower risk for asthma and asthma risk decreases as the number of older siblings increases, possibly due to increased exposure to microorganisms and their products through contact with older siblings (2,5).

Understanding how the human microbiome is shaped and affects health can provide mechanistic explanation to the hygiene hypothesis, which could help guide exposure recommendations or microbe-based therapeutics for disease prevention and modification (5,6).

A ubiquitous gastro-intestinal microorganism is Toxoplasma gondii, an obligate intracellular protozoan whose definitive host is cats. People become infected with T. gondii through indirect fecal-oral transmission or consumption of undercooked meat. About 12% of the U.S. population is infected, and in some countries, prevalence is as high as 60% (7,8). Despite recognized impacts on the mammalian immune response, the relationship between T. gondii infection and asthma has not been well investigated (6,8). In the current study, we quantify the association between T. gondii infection and asthma in the U.S. population.

METHODS

We used a cross-sectional study design to examine a public database of U.S. residents aged 6 to 80 years or older from the 2012-2014 survey cycles of the American National Health and Nutrition Examination Survey (NHANES). This is a continuous survey based on a stratified multistage clustered probability design to select a representative sample of the civilian, noninstitutionalized U.S. population (9). Identification of individuals is not possible from these data. Only subjects 6 years of age or older were tested for T. gondii. Demographic, socioeconomic, and health-related information were taken from the NHANES Questionnaire, and serological data from the NHANES surplus sera program (2012-2014). The data were accessed on October 16th, 2023.

The University of British Columbia’s Policy LR9, item 7.10.3, on studies involving human participants and Article 2.2 of the Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans provide ethical support for this study (10,11). The NHANES protocols were approved by the National Center for Health Statistics institutional review board, and written informed consent was obtained from all participants (9).

The response rates for in-home interviews in 2011-2012 and 2013-2014 were 72.6 and 71.0%, respectively (9). Of the 19,931 persons interviewed, 16,733 (84%) were ≥ 6 years old. Of these 16,733 interviewed subjects, 12,677 (76%) had sera tested for T. gondii antibodies. Three of these subjects were excluded due to missing IgG results, and an additional 45 were excluded because they most likely had acute infections (exposure occurred within the last two weeks); the cross-sectional NHANES data would probably not capture the effects of an acute infection (12). Nine subjects were excluded because the outcome of asthma was missing, resulting in an analytic sample of n = 12,620 (Fig 1, Table 1).

View this table:
  • View inline
  • View popup
Table 1.

Sample characteristics (frequencies and percentages) of individuals from the NHANES 2011-2014 survey cycles and their Toxoplasma gondii infection status, stratified by the outcome self-reported asthma severity (0 = “never been told you have asthma”; 1 = “told you have asthma”; 2 = “told you have asthma and still have asthma”; 3 = “still have asthma and had an asthma attack in the past year”; and 4 = “had an emergency care visit for asthma in the past year). Rao-Scott Chi-squared tested for differences between asthma severity and the identified confounders; statistically significant p-values (p <0.05) are bolded.

Fig 1.
  • Download figure
  • Open in new tab
Fig 1.

Flowchart representing the process for selecting the analytic sample from the NHANES 2012-2014 survey cycle data to evaluate the association between Toxoplasma gondii infection and asthma in the U.S.

The exposure variable was infection with T. gondii, defined as having IgG antibodies to T. gondii above ≥33 IU/mL. IgG antibodies were measured with the Toxoplasma IgG Enzyme Immunoassay (Bio-Rad, Redmond, WA) and IgM antibodies with the Platelia Toxo IgM (Bio-Rad). Test results were expressed as international units (IU/mL) or sample ratios, respectively. If IgG assay results were missing, the subject was excluded from the analysis (n = 3). If IgG was positive and IgM was missing, the exposure was counted as “positive”. If IgG was negative (<33 IU/mL), and IgM was missing, the exposure was counted as “negative”. If IgG was negative, and IgM was positive (Sample Ratio ≥1) the exposure was categorized as “acute” and excluded from the analysis (n = 45) (Fig 1)(12).

We created a proxy variable representing five levels of asthma severity from five variables in the Questionnaire. Level 0 indicates “never been told you have asthma”, level 1, “told you have asthma”, level 2, “told you have asthma and still have asthma”, level 3 “still have asthma and had an asthma attack in the past year” and level 4 “had an emergency care visit for asthma in the past year”. For comparison, we created a binary outcome variable for asthma based on the question, “Has a doctor or other health professional ever told you that you have asthma?” “Yes” or “No”.

We selected the minimum sufficient adjusted set of confounders using the modified disjunctive cause criterion, informed by evidence in the current literature and a directed acyclic graph (DAG) (Fig 2)(1,7,13–17). As cat ownership is not an important risk factor for T. gondii infection, and pet ownership information was not collected in the 2012-2014 NHANES, cat ownership was not included as a covariate (18–23). Because the NHANES categorizes subjects over the age of 80 years as “80+”, we grouped the age variable into decades as follows: “6-9”; “10-19”; “20-29”; “30-39”; “40-49”; “50-59”; “60-69”; “70-79”; and “80+”. This grouping is consistent with other analyses of T. gondii infection and is a clinically relevant interval for assessing trends in asthma severity and T. gondii seropositivity (7,24,25).

Fig 2.
  • Download figure
  • Open in new tab
Fig 2.

Directed acyclic graph illustrating the relationships amongst the exposure variable “Toxoplasma gondii”, the outcome variable “Asthma severity”, and adjusted confounders. T. gondii infection is characterized as positive (pos) or negative (neg) and Asthma severity is categorized from 0 to 4, where 0 indicates no asthma and 4 indicates the subject has asthma that caused at least one emergency room visit in the last year. Age is age in years at last birthday. Education refers to the highest level of education attained by the household reference person. Poverty index refers to the poverty index assigned to the household reference person and # Children is the number of children <18 years of age living in the household.

Gender was “male” or “female”. Race was categorized as “Hispanic”, “White”, “Black”, “Asian”, or “other” according to the respondent’s self-assessment. Country of birth was “U.S.” or “other”. The education level of the household reference person was categorized as “<9th grade”, “9th-11th grade”, “high school”, “some college”, or “college completed”. Economic status was defined according to the poverty index of the household reference person and expressed as a continuous numeric variable (0-5), where a poverty index of ≥3.5 indicates a high level of poverty (26). Number of children in the household was 0-3 or greater than 4 (9).

It is not clear from the literature if level of education is associated with asthma after adjusting for income (13,24). We calculated Akaike information criteria (AICs) for the ordinal and logistic regression models with and without the variable “education of the household reference person” to evaluate model fit. In both cases, model fit was improved by including the level of education in the model.

We tested for interaction effect between: “age” and “poverty index”, “race” and “poverty index”; and “poverty index” and “number of children in the household.” There was no significant interaction between “age” and “poverty index”. We detected significant interaction (p<0.05) for the latter two combinations and included these interaction terms in the final model.

Because T. gondii infection and asthma prevalence vary with age (Fig 3), and the relationship between asthma and atopy could also differ with age (2), we conducted additional ordinal regression analyses stratified by age category to check for effect modification and calculated the AIC values to compare model fit (Table 3).

Fig 3.
  • Download figure
  • Open in new tab
Fig 3.

Toxoplasma gondii and asthma prevalence by age category in the U.S. non-institutionalized civilian population age 6 years and older. Data is from the NHANES 2011-2014 survey cycles (n=12,620).

Analyses were performed in R (version 4.3.1)(27). We used a design-based analysis approach to account for survey weights and complex survey design using the CRAN survey package (version 4.2-1)(28). Descriptive statistics are presented in Table 1; reported frequencies are based on the unweighted analytic sample while the percentages account for complex survey design.

Among all subjects, country of birth was missing for 0.03%, education level was missing for 3.29%, poverty index was missing for 6.86%, and age was missing for 19.0%. We assumed the data were missing at random (MAR) and imputed the missing covariate data using five imputations (29). All analyses were conducted on each imputed data set and results were pooled using Rubin’s rules (30). We compared results using imputed data with those obtained from a complete case analysis.

We fit an ordinal logistic regression model to estimate odds ratios (OR) and 95% confidence intervals (CI) of the unadjusted association between T. gondii infection and asthma severity (0-4), and the association after adjusting for all confounders (Table 2). For comparison, we fit a logistic regression model to estimate the unadjusted and fully adjusted association between T. gondii infection and asthma as a bivariate outcome, “Yes” or “No”.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2.

Odds ratios (OR) and 95% confidence intervals (CI) for the unadjusted and adjusted relationship between Toxoplasma gondii infection status and asthma in the U.S. non-institutionalized civilian population age 6 years and older. Asthma is expressed as an ordinal categorical variable with levels of severity 0-4 in an ordinal logistic regression model and as a bivariate yes/no variable in a logistic regression model. Data is from the NHANES 2011-2014 survey cycles.a

RESULTS

Of the 12,620 subjects 6 years of age or older tested for T. gondii infection, 10.8% were seropositive and 89.2% were seronegative. Most subjects (83.5%) reported that they had never been told that they had asthma (level 0), while 16.5% reported varying degrees of asthma severity (levels 1-4). Asthma prevalence varied by age category (Fig 3), with the highest prevalence found in 10–29-year-olds and the lowest in subjects 80 years and older. Prevalence of T. gondii infection increased with age (Fig 3). No statistically significant difference was detected for seroprevalence of T. gondii across the five levels of asthma severity (p = 0.140). Significant unadjusted associations between asthma and the covariates gender (p = 0.036), age category (p = 0.019), poverty index (p = 0.003), and race (p = 0.024) are presented in Table 1.

No significant relationship was detected between T. gondii infection and asthma. A complete case analysis using the unadjusted ordinal regression model returned an OR of 0.89 (95% CI = 0.79-1.01), suggesting an insignificant protective effect of T. gondii infection. Adjusting for all confounders, the complete case model returned an OR of 1.02 (95% CI 0.87-1.19). Using multiple imputation to account for missing covariate data, the unadjusted regression model returned an OR of 0.90 (95% CI = 0.83-0.97), suggesting a protective effect of T. gondii infection, but the fully adjusted model returned an OR of 1.00 (95% CI = 0.91-1.10), confirming there was no detected association between T. gondii infection and asthma (Table 2). The unadjusted and adjusted logistic regression models evaluating asthma as a bivariate outcome variable (Yes/No) yielded similar results (Table 2). The ordinal model fit the data better than the logistic model according to the AIC values.

Regression analyses stratified by age category suggested that there is some effect modification by age. Model fit, evaluated using AIC, was much better within age categories when compared to the full model using all age categories (Table 3). The association between T. gondii infection and asthma severity also varied across age categories, but within each category, the association remained insignificant (Table 3).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3.

Odds ratios (OR) and 95% confidence intervals (CI) for the relationship between Toxoplasma gondii infection status and asthma in the U.S. non-institutionalized civilian population, stratified by age category. Asthma is expressed as an ordinal categorical variable with levels of severity 0-4. Model fit is compared using AICa. Data is from the NHANES 2011-2014 survey cycles.

DISCUSSION

The NHANES data has some limitations. An estimated 20% of asthma cases are undiagnosed in the U.S. and therefore not captured by the NHANES (31), which could bias our results.

Additionally, the data are cross-sectional and cannot capture temporal relationships between exposure and outcome. If T. gondii exerts an effect on asthma over only a short period post-infection, our analysis might fail to detect this. Furthermore, asthma is a syndrome comprised of several diseases, not all of which are associated with atopy (4). Because T. gondii’s potential impact on asthma is postulated to occur via immune system modulation (6,32), the inability to distinguish atopy-related asthma from other types might reduce the sensitivity of our analysis.

Model fit was improved when stratified by age category, and ORs appeared to vary across age categories but remained statistically insignificant (Table 3). The non-linear relationship between asthma and age (Fig 3) might contribute to this effect.

For all adjusted regression models, no significant relationship was detected between T. gondii infection and asthma. These findings are consistent with two other large cross-sectional studies in Scotland and Australia that found no association between T. gondii seropositivity and asthma (14,33). While our results appear to contradict several case-control studies that have found a protective effect of T. gondii infection on allergy symptoms and asthma, these studies did not consider confounders which could impact exposure to a diversity of microorganisms and their products, such as socioeconomic status or number of siblings (34,35). Toxoplasma gondii is, therefore, likely a marker for the protective effect of exposure to a diversity of microbial organisms and their products early in life, but may not have any causal effect on this phenomenon, or may not be important when considered in isolation (1,7,15,36).

Data Availability

All data files are available from the 2012-2014 survey cycles of the American National Health and Nutrition Examination Survey (NHANES) and are available from https://wwwn.cdc.gov/nchs/nhanes/

https://wwwn.cdc.gov/nchs/nhanes/

ACKNOWLEDGMENTS

The author thanks Michael Asamoah-Boaheng who reviewed preliminary drafts of this manuscript.

Footnotes

  • hezy86{at}student.ubc.ca

WORKS CITED

  1. 1.↵
    Dannemiller KC, Gent JF, Leaderer BP, Peccia J. Indoor microbial communities: Influence on asthma severity in atopic and nonatopic children. J Allergy Clin Immunol. 2016 Jul;138(1):76-83.e1.
    OpenUrlCrossRef
  2. 2.↵
    Eder W, Ege MJ, von Mutius E. The Asthma Epidemic. N Engl J Med. 2006 Nov 23;355(21):2226–35.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.
    Most Recent National Asthma Data | CDC [Internet]. 2023 [cited 2023 Nov 12]. Available from: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm
  4. 4.↵
    Nurmagambetov T, Kuwahara R, Garbe P. The Economic Burden of Asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018 Mar;15(3):348–56.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Liu AH. Revisiting the hygiene hypothesis for allergy and asthma. J Allergy Clin Immunol. 2015 Oct;136(4):860–5.
    OpenUrlCrossRef
  6. 6.↵
    Fenoy IM, Sánchez VR, Soto AS, Picchio MS, Martin V, Goldman A. Toxoplasma gondii infection modulate systemic allergic immune response in BALB/c mice. Exp Parasitol. 2015 Jul;154:47–50.
    OpenUrl
  7. 7.↵
    Jones JL, Kruszon-Moran D, Elder S, Rivera HN, Press C, Montoya JG, et al. Toxoplasma gondii Infection in the United States, 2011–2014. Am J Trop Med Hyg. 2018 Feb 7;98(2):551–7.
    OpenUrlCrossRef
  8. 8.↵
    Wagner A, Förster-Waldl E, Garner-Spitzer E, Schabussova I, Kundi M, Pollak A, et al. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice. Int J Parasitol. 2009 Mar;39(4):465–72.
    OpenUrlCrossRefPubMed
  9. 9.↵
    NHANES Questionnaires, Datasets, and Related Documentation [Internet]. [cited 2023 Oct 15]. Available from: https://wwwn.cdc.gov/nchs/nhanes/
  10. 10.↵
    Government of Canada IAP on RE. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans – TCPS 2 (2018) [Internet]. 2019 [cited 2023 Oct 11]. Available from: https://ethics.gc.ca/eng/policy-politique_tcps2-eptc2_2018.html
  11. 11.↵
    Human Research Policy. 2019;
  12. 12.↵
    Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002 Feb 15;185 Suppl 1:S73–82.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Aydogan M, Ozen A, Akkoc T, Eifan AO, Aktas E, Deniz G, et al. Risk factors for persistence of asthma in children: 10-year follow-up. J Asthma. 2013 Nov 1;50(9):938–44.
    OpenUrl
  14. 14.↵
    Bodner C, Anderson WJ, Reid TS, Godden DJ. Childhood exposure to infection and risk of adult onset wheeze and atopy. Thorax. 2000 May 1;55(5):383–7.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Iqbal S, Oraka E, Chew GL, Flanders WD. Association Between Birthplace and Current Asthma: The Role of Environment and Acculturation. Am J Public Health. 2014 Feb;104(Suppl 1):S175–82.
    OpenUrlCrossRefPubMed
  16. 16.
    Mareze M, Benitez ADN, Brandão APD, Pinto-Ferreira F, Miura AC, Martins FDC, et al. Socioeconomic vulnerability associated to Toxoplasma gondii exposure in southern Brazil. Carvalho LH, editor. PLOS ONE. 2019 Feb 14;14(2):e0212375.
    OpenUrl
  17. 17.↵
    Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989 Nov 18;299(6710):1259–60.
    OpenUrlFREE Full Text
  18. 18.↵
    Wei HX, He C, Pl Y, Lindsay D, Peng HJ. Relationship Between Cat Contact and Infection by Toxoplasma gondii in Humans: A Meta-Analysis. Comp Parasitol. 2016 Jan 1;83:11–9.
    OpenUrl
  19. 19.
    Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ. 2000 Jul 15;321(7254):142–7.
    OpenUrlAbstract/FREE Full Text
  20. 20.
    Stray-Pedersen B, Lorentzen-Styr AM. Epidemiological aspects of Toxoplasma infections among women in Norway. Acta Obstet Gynecol Scand. 1980;59(4):323–6.
    OpenUrlPubMedWeb of Science
  21. 21.
    Wallace MR, Rossetti RJ, Olson PE. Cats and toxoplasmosis risk in HIV-infected adults. JAMA. 1993 Jan 6;269(1):76–7.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.
    Markovic-Denic L, Stopic M, Bobic B, Nikolic V, Djilas I, Srzentic SJ, et al. Factors Associated with Toxoplasma gondii Seroprevalence in Pregnant Women: A Cross-Sectional Study in Belgrade, Serbia. Pathogens. 2023 Oct 13;12(10):1240.
    OpenUrl
  23. 23.↵
    Kapperud G, Jenum PA, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Risk Factors for Toxoplasma gondii Infection in Pregnancy: Results of a Prospective Case-Control Study in Norway. Am J Epidemiol. 1996 Aug 15;144(4):405–12.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    Ahmed AE, AL-Jahdali H, AL-Harbi A, Khan M, Ali Y, Al Shimemeri A, et al. Factors associated with poor asthma control among asthmatic patient visiting emergency department. Clin Respir J. 2014;8(4):431–6.
    OpenUrl
  25. 25.↵
    Matricardi PM, Rosmini F, Panetta V, Ferrigno L, Bonini S. Hay fever and asthma in relation to markers of infection in the United States. J Allergy Clin Immunol. 2002 Sep;110(3):381–7.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    ASPE [Internet]. [cited 2023 Oct 15]. Prior HHS Poverty Guidelines and Federal Register References. Available from: https://aspe.hhs.gov/topics/poverty-economic-mobility/poverty-guidelines/prior-hhs-poverty-guidelines-federal-register-references
  27. 27.↵
    How to Cite R and R Packages. 00:00 + UTC [cited 2023 Nov 12]; Available from: https://ropensci.org/blog/2021/11/16/how-to-cite-r-and-r-packages/
  28. 28.↵
    survey citation info [Internet]. [cited 2023 Nov 12]. Available from: https://cran.r-project.org/web/packages/survey/citation.html
  29. 29.↵
    Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009 Sep 1;338(jun29 1):b2393–b2393.
    OpenUrlFREE Full Text
  30. 30.↵
    Introduction. In: Multiple Imputation for Nonresponse in Surveys [Internet]. John Wiley & Sons, Ltd; 1987 [cited 2023 Nov 13]. p. 1–26. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/9780470316696.ch1
  31. 31.↵
    Bruzzese JM, Kingston S, Falletta KA, Bruzelius E, Poghosyan L. Individual and Neighborhood Factors Associated with Undiagnosed Asthma in a Large Cohort of Urban Adolescents. J Urban Health Bull N Y Acad Med. 2019 Apr;96(2):252–61.
    OpenUrl
  32. 32.↵
    Fenoy I, Giovannoni M, Batalla E, Martin V, Frank FM, Piazzon I, et al. Toxoplasma gondii infection blocks the development of allergic airway inflammation in BALB/c mice. Clin Exp Immunol. 2009 Jan 6;155(2):275–84.
    OpenUrlCrossRefPubMed
  33. 33.↵
    Molan A, Nosaka K, Hunter M, Wang W. Seroprevalence and associated risk factors of Toxoplasma gondii infection in a representative Australian human population: The Busselton health study. Clin Epidemiol Glob Health. 2020 Sep;8(3):808–14.
    OpenUrl
  34. 34.↵
    Ellertsen LK, Hetland G, Løvik M. Specific IgE to Respiratory Allergens and IgG Antibodies to Toxoplasma gondii and Streptococcus pneumoniae in Norwegian Military Recruits. Scand J Immunol. 2008 May;67(5):496–500.
    OpenUrlPubMed
  35. 35.↵
    Elkholy A, Elsadek A, Eraky M, ElBishry M, Mohamed B. Seropostivity of Toxoplasma gondii in Children with Bronchial Asthma at Benha University Hospital, Egypt. Zagazig Univ Med J. 2021 Nov 4;0(0):0–0.
    OpenUrl
  36. 36.↵
    von Mutius E. Allergies, infections and the hygiene hypothesis--the epidemiological evidence. Immunobiology. 2007;212(6):433–9.
    OpenUrlCrossRefPubMedWeb of Science
Back to top
PreviousNext
Posted May 09, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The association between Toxoplasma gondii infection and asthma in the United States: A cross-sectional survey analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The association between Toxoplasma gondii infection and asthma in the United States: A cross-sectional survey analysis
Heather Anholt
medRxiv 2024.05.08.24307043; doi: https://doi.org/10.1101/2024.05.08.24307043
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The association between Toxoplasma gondii infection and asthma in the United States: A cross-sectional survey analysis
Heather Anholt
medRxiv 2024.05.08.24307043; doi: https://doi.org/10.1101/2024.05.08.24307043

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)